Concepedia

Xiaomeng Hu

XH

Statistics

Publications

19

Citations

1.9K

H-Index

16

Active since

2014

Affiliations

University of California, San Francisco(Current)

Sana Biotechnology (United States)

University Medical Center Hamburg-Eppendorf

Stanford University

Parker Institute for Cancer Immunotherapy

Xiaomeng Hu is an author at University of California, San Francisco specializing in immunology, life sciences, and oncology.

ORCID

Publications per year

2014–2025

19

Publications

19

Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients

T. Deuse, Xiaomeng Hu, Alessia Gravina et al. · Nature Biotechnology · 2019 · 735 citations

, , +12

The SIRPα–CD47 immune checkpoint in NK cells

T. Deuse, Xiaomeng Hu, Sean Agbor-Enoh et al. · The Journal of Experimental Medicine · 2020 · 199 citations · Full text

, , +17

Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques

Xiaomeng Hu, Kathy White, Ari G. Olroyd et al. · Nature Biotechnology · 2023 · 148 citations · Full text

, , +17

De novo mutations in mitochondrial DNA of iPSCs produce immunogenic neoepitopes in mice and humans

T. Deuse, Xiaomeng Hu, Sean Agbor-Enoh et al. · Nature Biotechnology · 2019 · 106 citations

, , +8

Human hypoimmune primary pancreatic islets avoid rejection and autoimmunity and alleviate diabetes in allogeneic humanized mice

Xiaomeng Hu, Corie Gattis, Ari G. Olroyd et al. · Science Translational Medicine · 2023 · 97 citations

, , +16

1–5 of 19